JP2023550459A5 - - Google Patents
Info
- Publication number
- JP2023550459A5 JP2023550459A5 JP2023530543A JP2023530543A JP2023550459A5 JP 2023550459 A5 JP2023550459 A5 JP 2023550459A5 JP 2023530543 A JP2023530543 A JP 2023530543A JP 2023530543 A JP2023530543 A JP 2023530543A JP 2023550459 A5 JP2023550459 A5 JP 2023550459A5
- Authority
- JP
- Japan
- Prior art keywords
- heavy chain
- variable region
- antibody construct
- antigen
- chain variable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063117379P | 2020-11-23 | 2020-11-23 | |
| US63/117,379 | 2020-11-23 | ||
| PCT/IB2021/060796 WO2022107090A1 (en) | 2020-11-23 | 2021-11-22 | Expression technology for antibody constructs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023550459A JP2023550459A (ja) | 2023-12-01 |
| JP2023550459A5 true JP2023550459A5 (enExample) | 2024-11-29 |
Family
ID=78819584
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023530543A Pending JP2023550459A (ja) | 2020-11-23 | 2021-11-22 | 抗体構築物の発現技術 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250282894A1 (enExample) |
| EP (1) | EP4247857A1 (enExample) |
| JP (1) | JP2023550459A (enExample) |
| CN (1) | CN116615462A (enExample) |
| WO (1) | WO2022107090A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117402253B (zh) * | 2023-08-02 | 2024-08-23 | 南京大学 | 一种抗哇巴因的纳米抗体及其应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8003106B2 (en) * | 2002-03-13 | 2011-08-23 | Kyowa Hakko Kirin Co., Ltd. | Human monoclonal antibodies to influenza M2 protein and methods of making and using same |
| ES2546086T3 (es) | 2007-12-21 | 2015-09-18 | Novartis Ag | Sistema de selección en un cultivo de células eucariotas basado en un gen receptor de folato unido a la membrana |
| PT3027646T (pt) | 2013-07-31 | 2018-10-16 | Novartis Ag | Novos vetores e métodos de seleção de células hospedeiras eucarióticas |
| CN111499753B (zh) * | 2014-03-03 | 2022-10-21 | 高雄医学大学 | 双功能抗体及其用途 |
| CR20160519A (es) * | 2014-05-13 | 2017-01-27 | The Trustees Of The Univ Of Pennysylvania | Composiciones que comprenden avv que expresa constructos de anticuerpos duales y sus usos |
| US10144768B2 (en) | 2015-12-04 | 2018-12-04 | Novartis Ag | Antibody cytokine engrafted compositions and methods of use for immunoregulation |
-
2021
- 2021-11-22 WO PCT/IB2021/060796 patent/WO2022107090A1/en not_active Ceased
- 2021-11-22 CN CN202180077498.XA patent/CN116615462A/zh active Pending
- 2021-11-22 US US18/253,903 patent/US20250282894A1/en active Pending
- 2021-11-22 EP EP21816170.1A patent/EP4247857A1/en active Pending
- 2021-11-22 JP JP2023530543A patent/JP2023550459A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7140861B2 (ja) | ヘテロ二量体多重特異性抗体フォーマット | |
| JP5376759B2 (ja) | 二重特異性抗体 | |
| CN114450406B (zh) | 一种断裂型内含肽、使用其的重组多肽的制备方法 | |
| JP2021042257A5 (enExample) | ||
| JP2021525530A5 (enExample) | ||
| JP2023509212A5 (enExample) | ||
| JPH02500329A (ja) | ターゲット化多機能蛋白質 | |
| US20050032175A1 (en) | High affinity fusion proteins and therapeutic and diagnostic methods for use | |
| JP2008511337A5 (enExample) | ||
| EP1829895A1 (en) | Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies | |
| CA2410551A1 (en) | Heterodimeric fusion proteins | |
| DK2504359T3 (da) | Monospecifikke polypeptidreagenser | |
| Hober et al. | Bispecific applications of non-immunoglobulin scaffold binders | |
| CN118063620A (zh) | 双特异性抗体 | |
| JP2024507693A5 (enExample) | ||
| US20210221849A1 (en) | Artificial Protein Containing Antigen-Binding Region of Antibody and Being Fused With Physiologically Active Peptide | |
| CN113366104A (zh) | mRNA展示抗体文库和方法 | |
| US5911987A (en) | Cell surface protein and effector cell bonding reagent | |
| JP4160864B2 (ja) | 融合蛋白質、その製造方法及びそれを用いた評価方法 | |
| JP2023513512A5 (enExample) | ||
| JP2023057069A5 (enExample) | ||
| AU2024305189A1 (en) | Conjugated molecules | |
| KR101116872B1 (ko) | 면역원성이 증가된 펩티드 항원 및 이를 생산하는 방법 | |
| WO2024123708A1 (en) | Broadly neutralizing antibody-templated divalent immunogen vaccines | |
| RU2021110942A (ru) | Антигенсвязывающая молекула, содержащая измененную вариабельную область антитела |